- Filed
- May 6, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 1, 2024 | 4.4M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 4.18M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 4.1M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $2.67M |
| Capex | Q1 2024 · Mar 31, 2023 | $5.43M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$39.07M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$14.22M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $23.73M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $36.8M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$118.62M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$101M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $139.72M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $156.45M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $879.88M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $878.74M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $166.17M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $168.64M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $991.49M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1B |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$4.61 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$7.70 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$4.61 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$7.70 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $26.2M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $30.6M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$14.65M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$26.27M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$4.78M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$11.37M |
| Revenue | Q1 2024 · Mar 31, 2024 | $181.47M |
| Revenue | Q1 2024 · Mar 31, 2023 | $166.93M |